4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0000950170-24-023201
Options or other derivatives
- Chief Legal Officer acquired 125,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Sullivan Mark · Chief Legal Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-27 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +125,000 | 125,000 | D |
Loading xslF345X05/ownership.xml…